897 results on '"Ademi, Zanfina"'
Search Results
2. Australian Headache Epidemiology Data (AHEAD): a pilot study to assess sampling and engagement methodology for a nationwide population-based survey
3. Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review
4. The Burden of Type 2 Diabetes on the Productivity and Economy in Sub-Saharan Africa: A Life Table Modelling Analysis from a South African Perspective
5. Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis
6. Non-optimum temperatures led to labour productivity burden by causing premature deaths: A multi-country study
7. Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia
8. Cost-Effectiveness Analysis of Siltuximab for Australian Public Investment in the Rare Condition Idiopathic Multicentric Castleman Disease
9. Do clinical decision support tools improve quality of care outcomes in the primary prevention of cardiovascular disease: A systematic review and meta-analysis
10. Cost-effectiveness of lowering systolic blood pressure in reducing cardiovascular disease burden in Australia
11. Health economic analysis of polygenic risk score use in primary prevention of coronary artery disease – A system dynamics model
12. A systematic review and meta-analysis of short-stay programmes for total hip and knee replacement, focusing on safety and optimal patient selection
13. Stakeholder perspectives on short-stay joint replacement programs: results from a national cross-sectional study
14. Treatment costs for patients with Streptococcus suis infection in Northern Thailand: a hospital-based observational study of 14-year data
15. Equity in Economic Evaluations of Early Childhood Development Interventions in Low-and Middle-Income Countries: Scoping Review
16. Projecting the Health and Economic Burden of Cardiovascular Disease Among People with Type 2 Diabetes, 2022–2031
17. Exploring the Health and Economic Burden Among Truck Drivers in Australia: A Health Economic Modelling Study
18. Ambient PM2.5 and productivity-adjusted life years lost in Brazil: a national population-based study
19. Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the question
20. The Impact of Chronic Conditions on Productivity-Adjusted Life-Years in Both the Workplace and Household Settings in the General Adult Population in Finland
21. Early health technology assessment of gene silencing therapies for lowering lipoprotein(a) in the secondary prevention of coronary heart disease
22. A Causal Model for Primary Prevention of Cardiovascular Disease: The Health Economic Model for the Primary Prevention of Cardiovascular Disease
23. Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review
24. Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis
25. Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes
26. Combined population genomic screening for three high-risk conditions in Australia: a modelling study
27. Calling for Urgent Actions to Improve Lipid Management in Australia–Low Medication Adherence and Poor Therapeutic Goal Attainment Lead to Poor Outcomes and Wasted Resources
28. Estimating Australian Hospitalization Ratios and Costs for Wildtype SARS-CoV-2 in 2020
29. Guideline concordant prescribing following myocardial infarction in people who are frail: A systematic review
30. Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art Review
31. Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
32. A Systematic Review of Cost-Effectiveness of Non-Statin Lipid-Lowering Drugs for Primary and Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus
33. Promoting early childhood development in Viet Nam: cost-effectiveness analysis alongside a cluster-randomised trial
34. The burden and trend of diseases and their risk factors in Australia, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
35. Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions
36. Productivity-adjusted life years lost due to non-optimum temperatures in Brazil: A nationwide time-series study
37. Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification
38. Integrating the Biology of Cardiovascular Disease into the Epidemiology of Economic Decision Modelling via Mendelian Randomisation
39. Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data
40. The Hospitalizations for Cardiovascular and Respiratory Conditions, Emergency Department Presentations and Economic Burden of Bushfires in Australia Between 2021 and 2030: A Modelling Study
41. Cost-Effectiveness Analysis of Tobacco Control Strategies in Indonesia
42. Barriers and enablers to the implementation and sustainability of short‐stay arthroplasty programs for elective primary total hip and knee replacement: A systematic review with qualitative evidence synthesis
43. Estimating the benefits of obesity prevention on productivity: an Australian perspective
44. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
45. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.
46. Attainment of Low-Density Lipoprotein Cholesterol Goals in Statin Treated Patients: Real-World Evidence From Australia
47. Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims Data
48. Attainment of low-density lipoprotein cholesterol goals in patients treated with combination therapy: A retrospective cohort study in primary care
49. Projected New-Onset Cardiovascular Disease by Socioeconomic Group in Australia
50. Lifetime impact of being underweight or overweight/obese during childhood in Vietnam
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.